By contrast, other studies reported anti-inflammatory effects of GIP, including a reduction in neuroinflammation surrounding amyloid plaques in a mouse model of Alzheimer’s disease after chronic treatment with [D-Ala2]GIP or a dual GLP1R/GIPR agonist. Here, GIP is linked to early-onset autosomal dominant Alzheimer disease.